FDA approves Cialis to treat BPH (benign prostatic hyperplasia)
The U.S. Food and Drug Administration has today just approved Cialis (tadalafil) for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), a condition in which the prostate gland becomes enlarged, and for the treatment of BPH and erectile dysfunction (ED), when the conditions occur simultaneously. Cialis was approved in 2003 for the treatment of erectile dysfunction. Read more
More about:
This Site and third parties who place advertisements on this Site may collect and use information about your visits to this Site and other websites in order to provide advertisements about goods and services of interest to you. If you would like to obtain more information about these advertising practices and to make choices about online behavioral advertising, please click here
